Wada Kurato, Ueo Tetsuya, Yonemasu Hirotoshi, Togo Kazumi, Inoue Shotaro, Honda Hideho, Katsuta Makoto, Takahashi Haruhiko, Yao Kenshi, Murakami Kazunari
Department of Gastroenterology, Oita Red Cross Hospital, Oita, Japan.
Department of Pathology, Oita Red Cross Hospital, Oita, Japan.
Endosc Int Open. 2019 Sep;7(9):E1144-E1149. doi: 10.1055/a-0961-7916. Epub 2019 Aug 29.
White opaque substance (WOS) in gastric epithelial neoplasia is helpful for qualitative diagnosis of neoplasia. We hypothesized that WOS of neoplasia is strongly influenced by acid recovery after eradication, similar to that of gastric intestinal metaplasia. The aim of this study was to investigate whether antacids increase the appearance of the WOS in -eradicated neoplasia. A total of 38 gastric epithelial neoplasias (12 adenomas and 26 adenocarcinomas) detected after eradication were retrospectively evaluated. Presence or absence of WOS was evaluated by magnifying endoscopy with narrow band imaging before and after antacid administration. The pH of collected gastric juice was also measured. Study endpoints were (1) prevalence of WOS in the neoplasia before and after antacid administration, and the histological difference (adenoma and adenocarcinoma); and (2) relationship between the prevalence of WOS and gastric juice pH. WOS prevalence increased from 0 % (0/38) to 44.8% (17/38) after antacid administration. WOS prevalence in adenomas was more significantly increased compared to that in adenocarcinomas (83.3 % vs 26.9 %, = 0.0077). Prevalence of WOS in gastric neoplasias was only observed at neutral levels of gastric juice pH, and WOS was not observed at strong acidic levels. Antacid administration may increase the appearance of WOS in gastric epithelial neoplasia (especially adenomas) detected after eradication with acid recovery.
胃上皮肿瘤中的白色不透明物质(WOS)有助于肿瘤的定性诊断。我们假设肿瘤的WOS受根除后酸恢复的强烈影响,类似于胃肠化生的情况。本研究的目的是调查抗酸剂是否会增加根除后肿瘤中WOS的出现。 对根除后检测到的38例胃上皮肿瘤(12例腺瘤和26例腺癌)进行回顾性评估。在给予抗酸剂前后,通过窄带成像放大内镜评估WOS的有无。还测量了收集的胃液的pH值。研究终点为:(1)给予抗酸剂前后肿瘤中WOS的患病率及组织学差异(腺瘤和腺癌);(2)WOS患病率与胃液pH值之间的关系。 给予抗酸剂后,WOS患病率从0%(0/38)增至44.8%(17/38)。腺瘤中WOS的患病率相比腺癌显著升高(83.3%对26.9%,P = 0.0077)。胃肿瘤中WOS的患病率仅在胃液pH值为中性时观察到,在强酸性水平未观察到WOS。 给予抗酸剂可能会增加根除后伴酸恢复的胃上皮肿瘤(尤其是腺瘤)中WOS的出现。